CCL14 and diabetes mellitus: Prior work has shown CCL14 is one of a series of important “kidney risk inflammatory signature [KRIS]” inflammatory proteins circulating in patients with DM which may mediate the risk of progressing to end-stage kidney disease (ESKD) [7].